Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RMTI - ROCKWELL MEDICAL, INC.

IEX Last Trade
2.16
0.050   2.315%

Share volume: 1,759
Last Updated: Thu 26 Dec 2024 04:29:04 PM CET

PREVIOUS CLOSE
CHG
CHG%
$2.11
0.05
2.37%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.37%
1 Month
-6.93%
3 Months
-42.51%
6 Months
23.56%
1 Year
13.76%
2 Year
121.65%
Key data
Stock price
$2.16
P/E Ratio 
-18.60
DAY RANGE
$2.08 - $2.11
EPS 
-$0.16
52 WEEK RANGE
$1.26 - $5.15
52 WEEK CHANGE
$11.98
MARKET CAP 
88.746 M
YIELD 
N/A
SHARES OUTSTANDING 
31.030 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
1.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$580,869
AVERAGE 30 VOLUME 
$623,099
Company detail
CEO: Mark Strobeck
Region: US
Website: rockwellmed.com
Employees: 300
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Rockwell Medical, Inc. targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream.

Recent news